CCX’s Post

CCX reposted this

View profile for Nathan Sigworth, graphic

Helping to Build the Future of Market Access

Why I'm bullish on European market access: how #JCA is creating an opening to change how we work. #marketaccess #pharmaceutical #hta CCX World Evidence, Pricing and Access Congress

Why I’m Bullish on European Market Access (Part 1 of 4)

Why I’m Bullish on European Market Access (Part 1 of 4)

link.medium.com

Nathan Sigworth

Helping to Build the Future of Market Access

7mo

A quick question to the #lifesciences #vc and #privateequity investors in my network -- I'm curious how are you thinking about access scenarios for valuing new clinical assets you're investing in? Is the focus just IRA in the US or are you thinking about JCA in Europe as well? OrbiMed Alasdair Thong Barath Shankar Subramanian Julie Yoo Michael Sherman Michael Langer Dominic Schmidt Oliver Sexton Carl Bradford Byers Edward Kliphuis Rob Kniaz Vanela Bushi Simon Meier

Like
Reply

Great thoughts Nathan. A glass half full rather than half empty mindset is always useful in times of system change as it leave you open minded to new opportunities 🙂

Progressive optimism is needed. There is a lot of anxiety driven by uncertainty (a human reaction). But the principles of "good HTA" have not changed. We know how to do this. And agree, an opportunity for positive change - over time...

Like
Reply
Mark Trusheim

Biotech Exec including Precision Financing for Gene Therapies, Precision Medicine, & Platform Trials

7mo

May the pragmatic optimists prevail!

Beverly Kahn (We're RECRUITING)

Founder / President @ New Dimensions in Technology, Inc. | MBA

7mo

Great to hear from you Nate.

See more comments

To view or add a comment, sign in

Explore topics